Publication | Closed Access
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals
114
Citations
0
References
2011
Year
MedicineMetronomic TherapyClinical TrialsPathologyPharmacotherapyCancer TreatmentOncologyCancer Research
No additional data available for this publication yet. Check back later!